GENE ONLINE|News &
Opinion
Blog

2025-03-03|

Study Reveals Antidepressants May Hasten Cognitive Decline in Dementia Patients

by Mark Chiang
Share To

In a groundbreaking study published in BMC Medicine, researchers have found that the use of antidepressants could accelerate cognitive decline among individuals diagnosed with dementia. This discovery highlights the importance of careful prescription practices, as some antidepressants were identified to be less detrimental than others.

Antidepressants are commonly prescribed to manage symptoms associated with dementia, including anxiety, depression, aggressiveness, and sleep disturbances. The findings from this recent research could significantly influence how medical professionals approach treatment for dementia patients, aiming to mitigate potential risks associated with cognitive deterioration.

The study’s insights allow healthcare providers to make more informed decisions when prescribing these medications, potentially improving the quality of life for those affected by dementia. As the medical community continues to explore the complexities of dementia-related treatments, this research marks a crucial step in understanding and managing the implications of antidepressant use in this vulnerable population.

Date: February 26, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Higher Education Linked to Faster Cognitive Decline After Stroke
2025-03-27
Study Finds One in Eight Hospital Patients Are Critically Ill, Majority Treated Outside Intensive Care
2025-03-26
GSK Launches First-of-Its-Kind Study on Shingles Vaccine and Dementia Risk in the UK
2025-03-26
LATEST
Thermo Fisher Scientific to Acquire Sanofi’s Sterile Manufacturing Facility in Ridgefield, New Jersey
2025-07-17
Rethinking Liver Repair: Cellular Insights and Stem Cell Models Tackle Chronic Disease
2025-07-17
University Hospitals Test Methods to Preserve Unused Donor Hearts for Transplantation
2025-07-17
AI Model Reveals Alzheimer’s Drug Reduces Cognitive Decline by 46% in Early-Stage Patients
2025-07-17
Higher Copper Intake Linked to Improved Cognitive Performance in Older Adults
2025-07-17
Danaher India Partners with THSTI to Enhance Biomanufacturing Skills and Infrastructure in India
2025-07-17
Men Over 75 Now Face Highest Suicide Rates According to CDC Data
2025-07-17
EVENT
2025-07-23
BIO Asia–Taiwan 2025
Taipei, Taiwan
2025-08-08
HEALTHY AGEING TECH SHOW
Taipei, Taiwan
2025-08-09
MEDINFO 2025
Taipei, Taiwan
2025-09-03
BIO ASIA PACIFIC 2025
Bangkok, Thailand
2025-09-10
BIOHK 2025
Hong Kong
2025-10-01
Medical Japan 2025
Osaka, Japan
Scroll to Top